Observational study of compliance and continuance rates of raloxifene in the prevention and treatment of osteoporosis

Por Zanchetta, José R., Hakim, Carina, Lombas, Carola
Publicado em 2004

Tolerability of intravenous pamidronate for the treatment of osteoporosis and other metabolic osteopathies: A retrospective analysis

Por Sarli, Marcelo, Spivacow, Rodolfo, Pedroarias, Viviana, Roldán, Emilio J.A., Zanchetta, José R.
Publicado em 2007

Effect of Transdermal Teriparatide Administration on Bone Mineral Density in Postmenopausal Women

Por Cosman, Felicia, Lane, Nancy E., Bolognese, Michael A., Zanchetta, Jose R., Garcia-Hernandez, Pedro A., Sees, Karen, Matriano, James A., Gaumer, Kim, Daddona, Peter E.
Publicado em 2010

A Novel Monthly Dosing Regimen of Risedronate for the Treatment of Postmenopausal Osteoporosis: 2-Year Data

Por McClung, Michael R., Benhamou, Claude-Laurent, Man, Zulema, Tlustochowicz, Witold, Zanchetta, Jose R., Eusebio, Rachelle, Balske, Ana M., Matzkin, Ellen, Olszynski, Wojciech P., Recker, Robert, Delmas, Pierre D.
Publicado em 2012

Femoral and Vertebral Strength Improvements in Postmenopausal Women With Osteoporosis Treated With Denosumab

Por Keaveny, Tony M, McClung, Michael R, Genant, Harry K, Zanchetta, Jose R, Kendler, David, Brown, Jacques P, Goemaere, Stefan, Recknor, Chris, Brandi, Maria L, Eastell, Richard, Kopperdahl, David L, Engelke, Klaus, Fuerst, Thomas, Radcliffe, Hoi-Shen, Libanati, Cesar
Publicado no J Bone Miner Res (2014)